Justice Department Settles with NYU Langone and UPMC to Halt Youth Gender-Affirming Treatments
The Justice Department reached settlements with NYU Langone and the University of Pittsburgh Medical Center, requiring both to stop providing puberty blockers, hormones and certain surgeries to minors.
On Friday, the Justice Department disclosed settlement agreements with NYU Langone and the University of Pittsburgh Medical Center over the provision of gender-affirming care to minors. Both hospitals must discontinue the use of puberty-blocking medications, hormone treatments, and infrequent surgical interventions for patients under 18. These deals bring the total to at least six hospitals that have agreed to halt such services without admitting any legal violation.
The settlements align with the Trump administration’s stated aim of ending what it describes as “sex-rejecting procedures.” Since the announcements, a wave of hospitals nationwide has voluntarily stopped offering gender-affirming care, even when not directly targeted by legal action. NYU Langone said the agreement protects its patients from extensive government subpoenas. The broader impact marks a rapid shift in the availability of transgender health services for youth across the United States.
Why it matters
It signals a nationwide reduction in medical options for transgender youth and highlights the federal government’s role in shaping health policy.
In this story
Related stories
2 in this thread